Consumer / Employer

Walgreens Exec: Reimbursement Models Need to Catch Up with GLP-1 Demand

Walgreens is seeing “an enormous amount of demand” for injectable weight loss drugs, its president of U.S. healthcare said during the Reuters Total Health conference in Chicago. He declared that the healthcare industry needs to come up with a reimbursement model “that correctly compensates pharmacists and others” to administer these drugs. In his view, reimbursement hasn't caught up with the demand.

presented by
Health Tech

Why Tomorrow Health’s CEO Is Calling for More Caregiver Reimbursement

To address the burden faced by family caregivers across the country, Tomorrow Health CEO Vijay Kedar argues that the U.S. healthcare system should expand its reimbursement for the care they provide. Not only is caregiving physically and emotionally taxing, but it can also cause severe financial strain —many caregivers take time off work and spend their own money to support their loved ones’ care, he explained.